Filing Details

Accession Number:
0001203311-14-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-23 20:52:25
Reporting Period:
2014-01-21
Filing Date:
2014-01-23
Accepted Time:
2014-01-23 20:52:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seattle Genetics Inc SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202785 Eric Dobmeier 21823 30Th Drive Se
Bothell WA 98021
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-01-21 21,435 $47.87 112,408 No 4 S Direct
Common Stock Disposition 2014-01-21 19,616 $47.90 92,792 No 4 S Direct
Common Stock Disposition 2014-01-21 14,959 $48.02 77,833 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by Eric Dobmeier dated December 12, 2013.
  2. $47.8735 represents an average price per share for the shares sold on 1/21/2014. The sell price for shares sold on this day ranged from $47.10 to $49.07.
  3. Amount of Securities beneficially owned following reported transactions includes 61,334 Restricted Stock Units subject to vesting.
  4. $47.8955 represents an average price per share for the shares sold on 1/21/2014. The sell price for shares sold on this day ranged from $47.03 to $48.83.
  5. $48.0160 represents an average price per share for the shares sold on 1/21/2014. The sell price for shares sold on this day ranged from $47.03 to $48.83.